Clinical Trial Update: Phase 2 Study of XAF5 (XOPH5) Ointment for Reduction of Excess Eyelid Fat (Steatoblepharon) [Phase 2]

View source ↗

Summary

Phase 2 trial evaluated the efficacy and safety of XAF5 (XOPH5) Ointment for reducing excess eyelid fat (steatoblepharon); the study completed with results post…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Steatoblepharon

Drugs mentioned

• XAF5 (XOPH5) Ointment

Snippet

Sponsor: Topokine Therapeutics, Inc. | Conditions: Lower Eyelid Steatoblepharon (Excess Eyelid Fat) | Phase 2 | Status: COMPLETED | Results posted: 2016-02-08